Literature DB >> 1589398

Kinetics of degradation of levothyroxine in aqueous solution and in solid state.

C M Won1.   

Abstract

The kinetics of the deiodination of levothyroxine in aqueous solution were studied over the pH range 1 to 12. Temperature dependence of the reaction was also studied. The log k - pH profile indicated that the kinetics of deiodination include proton attack on the anion and dianion in acidic solution and water attack on the anion and dianion in alkaline solution. A possible mechanism of the deiodination was discussed. The solid-state stability of levothyroxine sodium was studied at elevated temperatures; and the compound was found to undergo deamination on heating. The decomposition follows biphasic first-order kinetics, with the most rapid decomposition occurring at the beginning of heating.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1589398     DOI: 10.1023/a:1018952415732

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  4 in total

1.  Deiodination of the iodinated amino acids.

Authors:  J B STANBURY
Journal:  Ann N Y Acad Sci       Date:  1960-04-23       Impact factor: 5.691

2.  [Thyroxine deiodination studied with instrumental analytical methods].

Authors:  A L Reviczky; S B Nagy
Journal:  Endokrinologie       Date:  1970-04

3.  Pitfalls in studies of in vitro deiodination of thyroxine.

Authors:  T Jolin; G Morreale de Escobar; F Escobar del Rey
Journal:  Endocrinology       Date:  1966-01       Impact factor: 4.736

4.  Determination of sodium levothyroxine in bulk, tablet, and injection formulations by high-performance liquid chromatography.

Authors:  J F Brower; D Y Toler; J C Reepmeyer
Journal:  J Pharm Sci       Date:  1984-09       Impact factor: 3.534

  4 in total
  12 in total

1.  Influence of formulation and processing factors on stability of levothyroxine sodium pentahydrate.

Authors:  Jarrod W Collier; Rakhi B Shah; Abhay Gupta; Vilayat Sayeed; Muhammad J Habib; Mansoor A Khan
Journal:  AAPS PharmSciTech       Date:  2010-05-08       Impact factor: 3.246

2.  Photochemical transformation of the thyroid hormone levothyroxine in aqueous solution.

Authors:  Jesper Svanfelt; Johan Eriksson; Leif Kronberg
Journal:  Environ Sci Pollut Res Int       Date:  2011-01-28       Impact factor: 4.223

3.  An investigation into the influence of experimental conditions on in vitro drug release from immediate-release tablets of levothyroxine sodium and its relation to oral bioavailability.

Authors:  Ivana Kocic; Irena Homsek; Mirjana Dacevic; Jelena Parojcic; Branislava Miljkovic
Journal:  AAPS PharmSciTech       Date:  2011-07-12       Impact factor: 3.246

4.  Provider and Patient Determinants of Generic Levothyroxine Prescribing: An Electronic Health Records-Based Study.

Authors:  Robert J Romanelli; Vani Nimbal; Sarah K Dutcher; Xia Pu; Jodi B Segal
Journal:  Ann Pharmacother       Date:  2017-04-20       Impact factor: 3.154

5.  Triazole Appending Agent (TAAG): A New Synthon for Preparing Iodine-Based Molecular Imaging and Radiotherapy Agents.

Authors:  Alla Darwish; Megan Blacker; Nancy Janzen; Stephanie M Rathmann; Shannon Czorny; Shawn M Hillier; John L Joyal; John W Babich; John F Valliant
Journal:  ACS Med Chem Lett       Date:  2012-02-18       Impact factor: 4.345

6.  Development and application of a validated HPLC method for the analysis of dissolution samples of levothyroxine sodium drug products.

Authors:  J W Collier; R B Shah; A R Bryant; M J Habib; M A Khan; P J Faustino
Journal:  J Pharm Biomed Anal       Date:  2010-10-13       Impact factor: 3.935

7.  Levothyroxine treatment and gastric juice pH in humans: the proof of concept.

Authors:  Camilla Virili; Giovanni Bruno; Maria Giulia Santaguida; Lucilla Gargano; Ilaria Stramazzo; Corrado De Vito; Alessia Cicenia; Giulia Scalese; Barbara Porowska; Carola Severi; Marco Centanni
Journal:  Endocrine       Date:  2022-04-27       Impact factor: 3.925

8.  Tablet splitting of a narrow therapeutic index drug: a case with levothyroxine sodium.

Authors:  Rakhi B Shah; Jarrod S Collier; Vilayat A Sayeed; Arthur Bryant; Muhammad J Habib; Mansoor A Khan
Journal:  AAPS PharmSciTech       Date:  2010-08-26       Impact factor: 3.246

9.  Synthesis and evaluation of morpholinoalkyl ester prodrugs of indomethacin and naproxen.

Authors:  V K Tammara; M M Narurkar; A M Crider; M A Khan
Journal:  Pharm Res       Date:  1993-08       Impact factor: 4.200

10.  TSH-based protocol, tablet instability, and absorption effects on L-T4 bioequivalence.

Authors:  Marisa Eisenberg; Joseph J Distefano
Journal:  Thyroid       Date:  2009-02       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.